Regnault A, Pompilus F, Ciesluk A, et al. Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30. Journal of Patient-Reported Outcomes. 2021;5(1):1-10.
Pompilus F, Ciesluk A, Marquis P, Griebsch I, Voorhaar M. Understanding the Patient Experience in NUT Carcinoma: Qualitative Interviews with Patients and Caregivers to Develop a Conceptual Framework. Oncol Ther. Aug 6 2021.
Klassen AF, Kaur MN, Tsangaris E, et al. ASO Visual Abstract: Development and Psychometric Validation of BREAST-Q Scales Measuring Cancer Worry, Fatigue, and Impact on Work. Annals of surgical oncology. May 27 2021.
Klassen AF, Kaur MN, Tsangaris E, et al. Development and Psychometric Validation of BREAST-Q Scales Measuring Cancer Worry, Fatigue, and Impact on Work. Annals of surgical oncology. May 24 2021.
Kaur MN, Klassen AF, Xie F, et al. An international mixed methods study to develop a new preference-based measure for women with breast cancer: the BREAST-Q Utility module. BMC women's health. 2021;21(1):8.
Zeidner JF, Mazerolle F, Bell JA, et al. Randomized Phase 2 Trial of Pevonedistat Plus Azacitidine Versus Azacitidine in Higher-Risk Myelodysplastic Syndromes/Chronic Myelomonocytic Leukemia or Low-Blast Acute Myeloid Leukemia: Exploratory Analysis of Patient-Reported Outcomes. 62nd American Society of Hematology Annual Meeting; 2020.
Popat R, Lonial S, Voorhees P, et al. DREAMM-2: Single-Agent Belantamab Mafodotin (Belamaf) Effects on Patient-Reported Outcome (PRO) Measures in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). 62nd American Society of Hematology Annual Meeting; 2020.
Eliason L, Loubert A, Gorsh B, Meunier J, Kleinman DM, Sapra SR, A. Methodology for Evaluating Meaningful Change Thresholds in Patient-Reported Outcome (PRO) Measures for Corneal Events in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Single-Agent Belantamab Mafodotin (BELAMAF). ISPOR; 2020.
Oza AM, Lorusso D, Aghajanian C, et al. Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. J Clin Oncol. 2020:Jco1903107.
Colombo N, Oza AM, Lorusso D, et al. The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma. Gynecologic Oncology. 2020.
Klassen AF, Dominici L, Fuzesi S, Cano SJ, et al. Development and Validation of the BREAST-Q Breast-Conserving Therapy Module. Annals of surgical oncology. 2020.
Kaur M, Pusic AL, Cano SJ, et al. International phase 1 study protocol to develop a health state classification system for a preference-based measure for women with breast cancer: the BREAST-Q Utility module. BMJ Open. 2020;10(1):e034451.
Young-Afat DA, Gibbons C, Klassen AF, Vickers AJ, Cano SJ, Pusic AL. Introducing BREAST-Q Computerized Adaptive Testing: Short and Individualized Patient-Reported Outcome Assessment following Reconstructive Breast Surgery. Plast Reconstr Surg. 2019;143(3):679-684.
Regnault A, Pompilus F, Ciesluk A, Mazerolle F, Bejar R, Fram RJ, et al. Creating customized patient-reported outcome measures for rare disease clinical trials: Application of the EORTC Item Library to hematological stem cell disorders. ISOQOL; San Diego, CA, USA, 2019.
Pompilus F, Bell JA, Fram RJ, Faller DV, Marquis P. Identification of the most suitable patient-reported outcome instrument for trials in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia. MDS International Symposium; Copenhagen, Denmark, 2019.
Lee EH, Pusic AL, Cano SJ, Klassen AF. The FACE-Q Skin Cancer Module addresses post-resection aesthetic and quality of life outcomes. British Journal of Dermatology. 2019;180(4):953-4.
Cracchiolo JR, Klassen AF, Young-Afat DA, Albornoz CR, Cano SJ, Patel SG, et al. Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q Head and Neck Cancer Module. Cancer. 2019;125(6):863-72.
Colombo N, Oza AM, Lorusso D, et al. Patient-Centred Outcomes in the Phase 3 Study ARIEL3 of Rucaparib Maintenance Treatment in Patients with Platinum-Sensitive, Recurrent Ovarian Carcinoma: Post Hoc Exploratory Analyses by BRCA Mutation Status and Patient Age. European Society of Gynecological Oncology 21st congress, 2019; Athens, Greece.
Bell JA, Pompilus F, Ciesluk A, Mazerolle F, Scipione F, Bejar R, et al. Understanding and Measuring Fatigue in Higher-Risk Myelodysplastic Syndromes, Chronic MyelomonocyticLeukemia, and Acute Myeloid Leukemia: Mixed Methods Research. MDS International Symposium; Copenhagen, Denmark, 2019.
Bell JA, Galaznik A, Pompilus F, Strzok S, Bejar R, Scipione F, et al. A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. J Patient Rep Outcomes. 2019;3(1):35.
Bedel J, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Amenedo Gancedo M, Fong PC, O’Malley DM, Meunier J, et al. Patient-Centered Outcomes in ARIEL3, a Phase 3, Randomized, Placebo-Controlled Study of Rucaparib Maintenance Treatment in Patients with Recurrent Ovarian Carcinoma. ISPOR; New Orleans, LA, USA, 2019.
Lee EH, Pusic AL, Cano SJ, Klassen AF. The FACE-Q Skin Cancer Module addresses post-resection aesthetic and quality of life outcomes. The British journal of dermatology. 2018.
Lee EH, Klassen AF, Cano SJ, Nehal KS, Pusic AL. FACE-Q Skin Cancer Module for Measuring Patient-Reported Outcomes Following Facial Skin Cancer Surgery. The British journal of dermatology. 2018.
Kaur M, Pusic A, Xie F, Bordeleau L, Matros E, Zhong T, et al. Development of health-state classification system for a new breast cancer-specific preference-based measure: the BREAST-Q. ISOQOL; 2018; Dublin, Ireland.
Bell JA, Pompilus F, Strzok S, Galaznik A, Scipione F, Fram RJ, et al. A pragmatic patient-reported outcome strategy for rare disease clinical trials: Application of the EORTC Item Library to Myelodysplastic Syndromes. ISOQOL; 2018; Dublin, Ireland.
Bell JA, Pompilus F, Galaznik A, Strzok S, Bejar R, Fram RJ, et al. Enhancing the Content of the EORTC QLQ-C30 to Maximize the Detection of Treatment Benefit in Hematological Stem Cell Disorders Using the EORTC Item Library. 60th American Society of Hematology Annual Meeting and Exposition; San Diego, CA, USA, 2018.
Bell JA, Pompilus F, Christian A, Mazerolle F, Scipione F, Bejar R, et al. Assessing Patient-Reported Outcomes in People with Myelodysplastic Syndromes: Can a Customized Selection of Items from the EORTC Library Enhance the EORTC QLQ-C30? 60th American Society of Hematology Annual Meeting and Exposition; San Diego, CA, USA, 2018.
Bell JA, Galaznik A, Pompilus F, Strzok S, Fram RJ, Faller DV, et al. Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia. 60th American Society of Hematology Annual Meeting and Exposition; San Diego, CA, USA, 2018.
Karagiannis T, Marquis P, Petersen J, Meyers OI, Chui SY, Campbell AK, et al. Understanding patients’ ability to function in order to inform clinical benefit in oncology studies. ISPOR; Glasgow, UK, 2017.
Karagiannis T, Marquis P, Petersen J, Meyers O, Chui SY, Campbell AK, et al. Beyond survival and tumor progression: Assessing patients' (pts') function to further define clinical benefit in oncology studies. American Societey of Clinical Oncology; Chicago, ILL, USA,2017.
Fuzesi S, Cano SJ, Klassen AF, Atisha D, Pusic AL. Validation of the electronic version of the BREAST-Q in the army of women study. Breast. 2017;33:44-9.
Bell JA, Pompilus F, Galaznik A, Strzok S, Bejar R, Fram RJ, et al. Enhancing the Content of the EORTC QLQ-C30 to Maximize the Detection of Treatment Benefit in Hematological Stem Cell Disorders Using the EORTC Item Library. American Society of Hematology annual meeting; Atlanta, GA, USA, 2017.
Bell JA, Galaznik A, Pompilus F, Strzok S, Fram RJ, Faller DV, et al. Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia. American Society of Hematology annual meeting; Atlanta, GA, USA, 2017.
Robinson DJ, Esseltine DL, Regnault A, Meunier J, Liu K, van De Velde H. The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials. Br J Haematol. 2016;174(3):368-81.
Lee EH, Klassen AF, Lawson JL, Cano SJ, Scott AM, Pusic AL. Patient experiences and outcomes following facial skin cancer surgery: A qualitative study. Australas J Dermatol. 2016;57(3):e100-4.
Lamarca A, Elliott E, Barriuso J, et al. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause? Cancer Treat Rev. 2016;44:26-41.
Regnault A, Ferrer L, Dinet J, Gabriel S, Pavel ME, Ruszniewski PB, et al. Health-Related Quality of Life in CLARINET, a phase III Trial of Lanreotide Autogel 120mg in Patients with Non-Functioning Entero-Pancreatic neuroendocrine Tumour: Analytical Challenges and Statistical Solutions. ISOQOL; Vancouver, Canada, 2015.
Klassen AF, Rosenberg-Yunger ZR, D'Agostino NM, Cano SJ, Barr R, Syed I, et al. The development of scales to measure childhood cancer survivors' readiness for transition to long-term follow-up care as adults. Health expectations : an international journal of public participation in health care and health policy. 2015;18(6):1941-55.
Klassen AF, Cano SJ, Sinha R, Shahbaz A, Klaassen R, Dix D. Is the Give Youth a Voice questionnaire an appropriate measure of teen-centred care in paediatric oncology: a Rasch measurement theory analysis. Health expectations : an international journal of public participation in health care and health policy. 2015;18(5):1686-97.
Socinski MA, Butts CA, Mitchell P, Thatcher N, Scagliotti G, Robinet G, et al. Exploration of patient health status as measured by the EQ-5D questionnaire alongside the START trial of tecemotide (L-BLP25) in NSCLC. World Conference on Lung Cancer; Sydney, Australia, 2013.
Pusic AL, Cemal Y, Albornoz C, Klassen A, Cano S, Sulimanoff I, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. Journal of cancer survivorship : research and practice. 2013;7(1):83-92.
Lee EH, Klassen AF, Nehal KS, Cano SJ, Waters J, Pusic AL. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population. Journal of the American Academy of Dermatology. 2013;69(2):e59-67.
Lee EH, Klassen A, Lawson JL, Cano SJ, Scott AM, Nehal KS, et al. A qualitative study to develop a conceptual framework to understand the health concerns of patients who undergo facial surgery for skin cancer. ISOQOL; Miami, FL, USA, 2013.
Lawson JL, Scott AM, Lee EH, Matros E, Albornoz CR, Price AN, et al. Quality of life and the impact of altered facial appearance in head and neck cancer patient populations: a qualitative study. ISOQOL; 2013; Miami, FL, USA.
Hoyt MA, Cano SJ, Saigal CS, Stanton AL. Health-related quality of life in young men with testicular cancer: validation of the Cancer Assessment for Young Adults (CAYA). Journal of cancer survivorship : research and practice. 2013;7(4):630-40.
Albornoz CR, Pusic AL, Reavey P, Scott AM, Klassen AF, Cano SJ, et al. Measuring health-related quality of life outcomes in head and neck reconstruction. Clinics in plastic surgery. 2013;40(2):341-9.
Scott AM, Ho AL, Klassen AF, Cano S, VanLaeken NY, Cordeiro P, et al. Patient-reported satisfaction with reconstructed breasts in the long-term survivorship period: Comparison of autologous and non-autologous breast reconstruction. American Society of Clinical Oncology; Chicago, IL, USA 2012.
Scott AM, Ho AL, Klassen A, Cano S, VanLaeken N, Cordeiro P, et al. Patient-reported satisfaction with reconstructed breasts in the long-term survivorship period: comparison of autologous and non-autologous breast reconstruction. ISOQOL; 2012; Budapest, Hungary
Pusic AL, Klassen AF, Scott AM, Cano SJ. Measuring and managing patient expectation for breast reconstruction: a new preoperative patient assessment tool. Appearance Matters 5; 2012; Bristol, UK
Pusic A, Klassen A, Scott AM, Cano S, Shouery M, Basch EM. Feasibility and acceptability of patient-reported outcomes data collection for clinical care following breast reconstruction. American Society of Clinical Oncology; 2012; Chicago, IL, USA
Pusic A, Cano S, Klassen A, Scott AM, Shouery M, Basch E, et al. Feasibility and acceptability of patient-reported outcomes data collection for clinical care following breast reconstruction. ISOQOL; Budapest, Hungary, 2012.
Price AN, Scott AM, Klassen A, Cano S, Mehrara BJ, Disa JJ, et al. Patient-reported satisfaction with psychosocial and sexual well-being and the nipple areola complex: comparison of preservation and reconstruction. ISOQOL; Budapest, Hungary, 2012.
Ho AL, Klassen A, Cano S, Scott AM, Pusic A. Optimizing satisfaction in breast reconstruction: the importance of the preoperative information and patient-physician communication. ISOQOL; Budapest, Hungary, 2012.
Gilet H, Regnault A. Analysis of time to patient-reported outcome meaningful change: illustration from a clinical trial of catumaxomab in patients with malignant ascites. International Society for Clinical Biostatistics (ISCB) 33rd Annual Conference; Bergen, Norway, 2012.
Delforge M, Dhawan R, Robinson DJ, Meunier J, Regnault A, Esseltine DL, et al. Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial. Eur J Haematol. 2012;89(1):16-27.
Albornoz CR, Matros M, Pusic A, Klassen A, Cano S, McCarthy C, et al. Breast reconstruction and radiation: an analysis of quality of life and satisfaction among patients undergoing implant reconstruction. ISOQOL; 2012; Budapest, Hungary.
Scott AM, Klassen AF, Pusic AL, Cano S, Cordeiro PG, Morrow M, et al. Adaptation of existing PRO measures for use in additional patient populations: The BREAST-Q© BCT Module. ISOQOL; 2011; Denver, CO, USA.
Matros E, Albornoz CR, Reavey PL, Cano SJ, Klassen AF, Pusic AL. Missing elements in current head and neck patient reported outcome measures. ISOQOL; 2011; Denver, CO, USA.
Gilet H, Bredart A, Regnault A, Bhandary D, Parasuraman B. An evaluation of statistical methods used to analyse patient-reported outcomes (PRO) data in published metastatic cancer studies. ISPOR; Madrid, Spain, 2011.
Snell LJ, Cano SJ, Klassen AF, McCarthy CM, Scott AM, Cordeiro PG, et al. Measuring and managing patient expectation for breast reconstruction: A new preoperative patient assessment tool. ISOQOL; 2010; London, UK.
Scott AM, McCarthy CM, Klassen AF, Cano SJ, Pusic AL, Jhanwar SM. Development of a new BREAST-Q module for Breast Cancer Patients: The Breast-Conserving Therapy (BCT) Module ISOQOL; London, UK, 2010.
Regnault A, Gater A, Battersby C, McIntosh S, Meunier J, Abetz L. Confirmation of Brief Pain Inventory Short Form (BPI-SF) 'worst pain' item cut-point for the assessment of pain progression in castration-resistant prostate cancer (CRPC). ISPOR; Prague, Czech Republic, 2010.
De Jong F, Viala-Danten M, Van Herwaarden R, Poppe K, Van Haaster C, Meunier J, et al. Psychometric validation of a patient questionnaire evaluating satisfaction with a darbepoetin alpha pre-filled device for self-injection (Aranesp® SureClick™ device), and a home-service (2care® service) in chemotherapy-induced anaemic cancer patients. ISPOR; Atlanta, USA, 2010.
Cano S, Klassen AF, Scott A, Thoma A, Feeny D, Pusic A. Health outcome and economic measurement in breast cancer surgery: challenges and opportunities. Expert Rev Pharmacoecon Outcomes Res. 2010;10(5):583-94.
Bredart A, Sultan S, Regnault A. Patient satisfaction instruments for cancer clinical research or practice. Expert Rev Pharmacoecon Outcomes Res. 2010;10(2):129-41.
Meunier J, Regnault A, Robinson DJ, Rosa K, San Miguel JF, Richardson PG, et al. Impact of tumor response on health-related quality of life (HRQoL) in newly diagnosed multiple myeloma patients treated with VELCADE/melphalan/prednisone (V-MP): Results from the VISTA trial. ISPOR Paris, France, 2009.
Klassen AF, Dix D, Cano SJ, Papsdorf M, Sung L, Klaassen RJ. Evaluating family-centred service in paediatric oncology with the measure of processes of care (MPOC-20). Child: care, health and development. 2009;35(1):16-22.
Dhawan R, Robinson DJ, Meunier J, Regnault A, Rosa K, Cakana A, et al. Sustained Health-Related Quality of Life (HRQoL) improvement in newly diagnosed multiple myeloma patients treated with bortezomib/melphalan/prednisone versus melphalan/prednisone: results from the VISTA trial. American Society of Hematology annual meeting; New Orleans, USA, 2009.
Dhawan R, Meunier J, Regnault A, Rosa K, Robinson DJ, Cakana A, et al. Impact of Complete Response on Health-Related Quality of Life in newly diagnosed multiple myeloma patients: results from the VISTA trial. 12th International Multiple Myeloma Workshop; Washington DC, USA, 2009.
Pusic A, Liu JC, Chen CM, Cano S, Davidge K, Klassen A, et al. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2007;136(4):525-35.
Pusic AL, Liu J, Chen CM, Cano S, Davridge K, Klassen A, et al. Health-Related Quality of Life in Head and Neck Cancer: A Review of Patient-Reported Outcome Measures. American Head and Neck Society Annual Meeting; Chicago, IL, USA, 2006.